Condensed Consolidated Statements of Operations (Unaudited) - USD ($)	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021
Income Statement [Abstract]
Fee income	$ 173,828	$ 213,123
Operating expenses	600,698	625,596
Research and development	148,825	145,178
Total expenses	749,523	770,774
Operating loss	(575,695)	(557,651)
Net investment (loss) income	(52,653)	344
Net loss	$ (628,348)	$ (557,307)
Basic and diluted net loss per common share	$ (0.02)	$ (0.02)
Weighted average number of common shares outstanding	31,650,396	31,634,890